Álvaro Ingles Russo Garces

6PUBLICATIONS
47CO-AUTHORS
Predictive and prognostic markersMolecular targetsEpidemiological methodsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Aug 27, 2025
Proteomic Landscapes of 3D and 2D Models of High-Grade Serous Ovarian Carcinoma: Implications for Carboplatin Response.

Jimmy Maillard, Theodoros I Roumeliotis, Ekta Paranjape

|Jun 27, 2025
Defactinib with avutometinib in patients with solid tumors: the phase 1 FRAME trial.

Susana Banerjee, Matthew G Krebs, Alastair Greystoke

|Mar 20, 2025
Racial Disparities in Endometrial Cancer Incidence and Outcomes in Brazil: Insights From Population-Based Registries.

Andréia Cristina de Melo, Jessé Lopes da Silva, Eduardo Paulino

|Aug 19, 2022
A Phase I Trial of CT900, a Novel α-Folate Receptor-Mediated Thymidylate Synthase Inhibitor, in Patients with Solid Tumors with Expansion Cohorts in Patients with High-Grade Serous Ovarian Cancer.

Susana Banerjee, Vasiliki Michalarea, Joo Ern Ang

|Jul 04, 2020
First-in-Human Study of AT13148, a Dual ROCK-AKT Inhibitor in Patients with Solid Tumors.

Robert McLeod, Rajiv Kumar, Dionysis Papadatos-Pastos

|Jul 31, 2019
Building on the anti-PD1/PD-L1 backbone: combination immunotherapy for cancer.

Alvaro H Ingles Garces, Lewis Au, Robert Mason

Pageof 1

Frequent Collaborators

4 joint publications

Udai Banerji

3 joint publications

Ruth Ruddle

2 joint publications

Anna Minchom

2 joint publications

Karen Swales